• Press Release

Mount Sinai Names New Chief of Pediatric Gastroenterology and Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center

  • New York, NY
  • (October 06, 2014)

Regarded as one of the world’s leading experts in the field of pediatric inflammatory bowel disease (IBD), Marla Dubinsky, MD, has been appointed Chief of Pediatric Gastroenterology in the Jack and Lucy Clark Department Department of Pediatrics at the Kravis Children’s Hospital at Mount Sinai, and Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center.

“Dr. Dubinsky brings years of expertise in clinical care and research to Mount Sinai, and we look forward to our division and Children’s IBD Center thriving under her leadership,” said Lisa Satlin, MD, Herbert H. Lehman Professor of Pediatrics at the Icahn School of Medicine and Chair of the Jack and Lucy Clark Department of Pediatrics at the Kravis Children’s Hospital at Mount Sinai.

In her new role, Dr. Dubinsky will lead the division in the care of infants, children and teens with digestive disorders through services that include pediatric endoscopy, the consultation and education for patients and families, and state-of-the-art diagnostic imaging services.

As Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Dr. Dubinsky will also oversee one of the largest programs for pediatric Crohn’s disease and ulcerative colitis in the country. The Center helps transition children seamlessly into the adult IBD program and provides care to young patients suffering from these diseases.

“We are delighted that Dr. Dubinsky will joining us in Mount Sinai’s transformative efforts in addressing inflammatory bowel disease, and that she shares our vision of world-class care for people with IBD of all ages,” said Bruce Sands, MD, Dr. Burrill B. Crohn Professor of Medicine at the Icahn School of Medicine and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology in the Samuel Bronfman Department of Medicine at The Mount Sinai Hospital.

“I am honored to be part of such a world class team dedicated to transforming the lives of children and young adults with digestive diseases including inflammatory bowel disease. To walk in the same hallways of some of the IBD greats including Dr. Burrill Crohn is both humbling and inspiring. The field is advancing rapidly and the team at Mount Sinai will continue to drive it forward and provide state of the art management to the community we serve," said Dr. Dubinsky.

Dr. Dubinsky’s primary research focuses on the influence of genetics and immune responses on the variability in clinical presentations, treatment responses and prognosis of early-onset IBD. Additional interests include the impact of IBD on fertility and pregnancy. She has published in 83 peer reviewed journals including Gastroenterology, The Journal of Pediatric Gastroenterology and Nutrition, Inflammatory Bowel Diseases, and the American Journal of Gastroenterology. She also currently sits on the editorial boards of several leading journals, including Gastroenterology, American Journal of Gastroenterology, and Nature Clinical Practice Gastroenterology & Hepatology.

She has received numerous honors and awards, most recently including one from the International Organization for the study of Inflammatory Bowel Disease She is a member of the American Gastroenterology Association, the American College of Gastroenterology, the North American Society of Pediatric Gastroenterology and Nutrition, the American Academy of Pediatrics, and the Crohn’s and Colitis Foundation of America.

Dr. Dubinsky joins Mount Sinai from Cedars-Sinai Medical Center, Los Angeles, California where she served as Director of the Pediatric Inflammatory Bowel Disease Center.

Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her Pediatric Residency at Alberta Children’s Hospital, Calgary, Canada and her Clinical Fellowship in Gastroenterology and Nutrition at Sainte-Justine Hospital at the University of Montreal, Quebec, Canada. She then completed her Research Fellowship in Inflammatory Bowel Disease at Cedars Sinai Medical Center.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.